Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The clotting defect in SLE.

M A Byron

    Clinics in Rheumatic Diseases
    |April 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Thrombosis is a significant issue in Systemic Lupus Erythematosus (SLE), often linked to coagulopathy and severe disease. Glomerular thrombosis on renal biopsy indicates more active inflammation and potential for worse outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Patient education: treatment or nice extra. The British experience.

    British journal of rheumatology·1996
    Same author

    Antibodies to cardiolipin in stroke: association with mortality and functional recovery in patients without systemic lupus erythematosus.

    The Quarterly journal of medicine·1991
    Same author

    Prevalence of anticardiolipin antibodies in the elderly British population.

    Postgraduate medical journal·1991
    Same author

    Anticardiolipin antibody associated ischaemic strokes in elderly patients without systemic lupus erythematosus.

    Age and ageing·1990
    Same author

    Clinical relevance of specific IgG antibodies of cardiolipin.

    Lancet (London, England)·1989
    Same author

    Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus.

    The Quarterly journal of medicine·1988
    Same journal

    Metabolic and endocrine aspects of rheumatic disease.

    Clinics in rheumatic diseases·1986
    Same journal

    Muscle 'contractures' and the 'stiff-man' syndrome.

    Clinics in rheumatic diseases·1986
    Same journal

    Hypophosphatasia.

    Clinics in rheumatic diseases·1986
    Same journal

    Alkaptonuria.

    Clinics in rheumatic diseases·1986
    Same journal

    Diabetes mellitus and rheumatic disease.

    Clinics in rheumatic diseases·1986
    Same journal

    Musculoskeletal manifestations of primary hyperparathyroidism.

    Clinics in rheumatic diseases·1986
    See all related articles

    Area of Science:

    • Nephrology
    • Rheumatology
    • Hematology

    Background:

    • Hemorrhagic complications are rare but serious in Systemic Lupus Erythematosus (SLE).
    • Thrombotic events are more common and contribute significantly to morbidity and mortality in SLE.
    • Low-grade coagulopathy is increasingly recognized as a factor in SLE pathology.

    Purpose of the Study:

    • To investigate the prevalence and significance of glomerular thrombosis in SLE.
    • To explore the relationship between circulating anticoagulants, coagulation factors, and renal pathology in SLE.

    Main Methods:

    • Analysis of clinical and histological features in SLE patients.
    • Examination of renal biopsies for glomerular thrombosis.
    • Assessment of circulating anticoagulants, factor VIII levels, and platelet counts.

    Related Experiment Videos

    Main Results:

    • A strong association was found between circulating anticoagulants and glomerular thrombosis.
    • Elevated factor VIII levels and decreased platelet counts correlated with active histological features.
    • Glomerulosclerosis was more frequent on re-biopsy in patients with initial glomerular thrombosis.

    Conclusions:

    • Glomerular thrombosis in SLE is associated with coagulopathy and indicates more severe disease activity.
    • Thrombosis may serve as a marker for increased inflammation and potentially worse renal outcomes in SLE.
    • Further understanding of thrombosis mechanisms could reveal new therapeutic targets for SLE.